Sequence features accurately predict genome-wide MeCP2 binding in vivo

Nature Communications

Volumn 7, Issue , 2016, Pages

  Rube, H Tomas ^a,b,c   Lee, Wooje ^d,e   Hejna, Miroslav ^a,b   Chen, Huaiyang ^d   Yasui, Dag H ^f   Hess, John F ^d   Lasalle, Janine M ^f   Song, Jun S ^a,b,g   Gong, Qizhi ^d  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b United States of America   (United States)

^c University of California School of Medicine ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Korea University   (South Korea)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; CHROMATIN; MECP2 PROTEIN, MOUSE; NUCLEOSOME; PROTEIN BINDING;

ACCURACY ASSESSMENT; BRAIN; DATA ACQUISITION; DNA; GENOME; GRAPHICAL METHOD; METHYLATION; PREDICTION; PROTEIN; RESOLUTION;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BRAIN DEVELOPMENT; CHROMATIN; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; FEMALE; GENE LOCATION; GENOME ANALYSIS; MALE; MOUSE; NERVE CELL; NONHUMAN; OLFACTORY EPITHELIUM; PROMOTER REGION; REPRESSOR GENE; TRANSCRIPTION REGULATION; ANIMAL; CHROMATIN IMMUNOPRECIPITATION; GC RICH SEQUENCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOSOME; NUCLEOTIDE SEQUENCE; OLFACTORY MUCOSA; SEQUENCE ANALYSIS;

ANIMALS; BASE SEQUENCE; BINDING SITES; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; GC RICH SEQUENCE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; METHYL-CPG-BINDING PROTEIN 2; MICE; NEURONS; NUCLEOSOMES; OLFACTORY MUCOSA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, RNA;

EID: 84962318130     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11025     Document Type: Article

References (52)

1. Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2: Nat. Genet. 23, 185-188 (1999).
2. Van Den Veyver, I. B. & Zoghbi, H. Y. Methyl-CpG-binding protein 2 mutations in Rett syndrome. Curr. Opin. Genet. Dev. 10, 275-279 (2000).
3. Lewis, J. D. et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905-914 (1992).
4. Skene, P. J. et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 37, 457-468 (2010).
5. Chandler, S. P., Guschin, D., Landsberger, N. & Wolffe, A. P. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry 38, 7008-7018 (1999).
6. Mellen, M., Ayata, P., Dewell, S., Kriaucionis, S. & Heintz, N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151, 1417-1430 (2012).
7. Baker, S. A. et al. An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell 152, 984-996 (2013).
8. Yasui, D. H. et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc. Natl Acad. Sci. USA 104, 19416-19421 (2007).
9. Gabel, H. W. et al. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome. Nature 522, 89-93 (2015).
10. Chahrour, M. et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224-1229 (2008).
11. Chen, W. G. et al. Derepression of BDNF transcription involves calciumdependent phosphorylation of MeCP2. Science 302, 885-889 (2003).
12. Ben-Shachar, S., Chahrour, M., Thaller, C., Shaw, C. A. & Zoghbi, H. Y. Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum. Mol. Genet. 18, 2431-2442 (2009).
13. Zhao, Y.-T., Goffin, D., Johnson, B. S. & Zhou, Z. Loss of MeCP2 function is associated with distinct gene expression changes in the striatum. Neurobiol. Dis. 59, 257-266 (2013).
14. Li, Y. et al. Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell 13, 446-458 (2013).
15. Yazdani, M. et al. Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons. Stem Cells 30, 2128-2139 (2012).
16. Cohen, S. et al. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72-85 (2011).
17. Baubec, T., Ivanek, R., Lienert, F. & Schubeler, D. Methylation-dependent and-independent genomic targeting principles of the MBD protein family. Cell 153, 480-492 (2013).
18. Lee, W. et al. MeCP2 regulates activity-dependent transcriptional responses in olfactory sensory neurons. Hum. Mol. Genet. 23, 6366-6374 (2014).
19. Diaz, A., Park, K., Lim, D. A. & Song, J. S. Normalization, bias correction, and peak calling for ChIP-seq. Stat. Appl. Genet. Mol. Biol. 11, Article 9 (2012).
20. Diaz, A., Nellore, A. & Song, J. S. CHANCE: Comprehensive software for quality control and validation of ChIP-seq data. Genome Biol. 13, R98 (2012).
21. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
22. Nan, X., Meehan, R. R. & Bird, A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res. 21, 4886-4892 (1993).
23. Nikitina, T. et al. Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin. Mol. Cell. Biol. 27, 864-877 (2007).
24. Lister, R. et al. Global epigenomic reconfiguration during mammalian brain development. Science 341, 1237905 (2013).
25. Stadler, M. B. et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 480, 490-495 (2011).
26. Shahbazian, M. D., Antalffy, B., Armstrong, D. L. & Zoghbi, H. Y. Insight into Rett syndrome: MeCP2 levels display tissue-and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 11, 115-124 (2002).
27. Chen, L. et al. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome. Proc. Natl Acad. Sci. USA 112, 5509-5514 (2015).
28. Meehan, R. R., Lewis, J. D. & Bird, A. P. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res. 20, 5085-5092 (1992).
29. Ishibashi, T., Thambirajah, A. A. & Ausió, J. MeCP2 preferentially binds to methylated linker DNA in the absence of the terminal tail of histone H3 and independently of histone acetylation. FEBS Lett. 582, 1157-1162 (2008).
30. Nikitina, T. et al. MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome. J. Biol. Chem. 282, 28237-28245 (2007).
31. Ozsolak, F., Song, J. S., Liu, X. S. & Fisher, D. E. High-throughput mapping of the chromatin structure of human promoters. Nat. Biotechnol. 25, 244-248 (2007).
32. Ozsolak, F. et al. Chromatin structure analyses identify miRNA promoters. Genes Dev. 22, 3172-3183 (2008).
33. Peckham, H. E. et al. Nucleosome positioning signals in genomic DNA. Genome Res. 17, 1170-1177 (2007).
34. Lee, W. et al. A high-resolution atlas of nucleosome occupancy in yeast. Nat. Genet. 39, 1235-1244 (2007).
35. Tillo, D. & Hughes, T. R. G C content dominates intrinsic nucleosome occupancy. BMC Bioinformatics 10, 442 (2009).
36. Nan, X. et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389 (1998).
37. Jones, P. L., Wade, P. A. & Wolffe, A. P. Purification of the MeCP2/histone deacetylase complex from Xenopus laevis. Methods Mol. Biol. 181, 297-307 (2001).
38. Tudor, M., Akbarian, S., Chen, R. Z. & Jaenisch, R. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl Acad. Sci. USA 99, 15536-15541 (2002).
39. Sugino, K. et al. Cell-type-specific repression by methyl-CpG-binding protein 2 is biased toward long genes. J. Neurosci. 34, 12877-12883 (2014).
40. Guy, J., Cheval, H., Selfridge, J. & Bird, A. The role of MeCP2 in the brain. Annu. Rev. Cell Dev. Biol. 27, 631-652 (2011).
41. Herculano-Houzel, S. & Lent, R. Isotropic fractionator: A simple, rapid method for the quantification of total cell and neuron numbers in the brain. J. Neurosci. 25, 2518-2521 (2005).
42. Benjamini, Y. & Speed, T. P. Summarizing and correcting the GC content bias in high-throughput sequencing. Nucleic Acids Res. 40, e72 (2012).
43. Aird, D. et al. Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome Biol. 12, R18 (2011).
44. Guy, J., Hendrich, B., Holmes, M., Martin, J. E. & Bird, A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27, 322-326 (2001).
45. Krueger, F. & Andrews, S. R. Bismark: A flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics 27, 1571-1572 (2011).
46. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357-359 (2012).
47. Derrien, T. et al. Fast computation and applications of genome mappability. PloS ONE 7, e30377 (2012).
48. Karolchik, D. et al. The UCSC genome browser database: 2014 update. Nucleic Acids Res. 42, D764-D770 (2014).
49. Kim, D. et al. TopHat2: Accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
50. Pruitt, K. D. et al. RefSeq: An update on mammalian reference sequences. Nucleic Acids Res. 42, D756-D763 (2014).
51. Trapnell, C. et al. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat. Biotechnol. 31, 46-53 (2013).
52. Smith, B., Williams, J. & Schulze-Kremer, S. The ontology of the gene ontology. AMIA Annu. Symp. Proc. 609-613 (2003).